BostonGene is a startup based in the United States, most recent round Series B, 1 tracked investor.
BostonGene is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
BostonGene is a biomedical software company that has developed an AI-driven molecular and immune profiling platform to identify and validate novel targets for personalized cancer therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.